Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu

Saved in:
Bibliographic Details
Title: Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu
Authors: De Grève, J.1 Jacques.degreve@uzbrussel.be, Teugels, E.1, Geers, C.1, Decoster, L.1, Galdermans, D.2, De Mey, J.1, Everaert, H.1, Umelo, I.1, Veld, P. In’t1, Schallier, D.1
Source: Lung Cancer (01695002). Apr2012, Vol. 76 Issue 1, p123-127. 5p.
Database: Academic Search Ultimate
Description
ISSN:01695002
DOI:10.1016/j.lungcan.2012.01.008